ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Cypherpunk Technologies Inc.
2.75
+0.9900
56.25%
盘后：
2.70
-0.0503
-1.83%
19:59 EST
成交量：
2.63亿
成交额：
7.66亿
市值：
1.56亿
市盈率：
-1.72
高：
3.55
开：
2.06
低：
1.89
收：
1.76
52周最高：
3.58
52周最低：
0.2223
股本：
5,665.18万
流通股本：
4,987.71万
量比：
1.59
换手率：
527.73%
股息：
- -
股息率：
- -
每股收益(TTM):
-1.6003
每股收益(LYR):
-1.8115
净资产收益率：
--
总资产收益率：
--
市净率：
--
市盈率(LYR):
-1.52
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字：
Cypherpunk Technologies Inc.
交易所：
NASDAQ
成立时间：
2011
员工人数：
52
公司地址：
47 Thorndike Street,Suite B1-1,Cambridge,Massachusetts,United States
官网：
http://www.leaptx.com
邮编：
02141
电话：
617 714 0360
传真：
- -
简介：
Cypherpunk Technologies Inc.最初作为Dekkun Corporation成立于2011年1月3日，是一家特拉华州公司。2025年11月13日，公司更名为Cypherpunk Technologies Inc.。该公司是一家开发新型生物标志物靶向抗体疗法的生物制药公司，旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。他们的策略是识别、获取和开发分子，这些分子将迅速转化为高影响的治疗方法，产生持久的临床效益并提高患者的预后。他们的主要临床阶段项目是DKN-01，一种抑制dickkopf相关蛋白1(“DKK1”)的单克隆抗体。他们目前正在多个正在进行的临床试验中研究DKN-01在食管胃癌、妇科癌症或结直肠癌患者中的应用。他们的第二个临床阶段项目是FL-301，这是一种针对细胞表面表达Claudin18.2的细胞的单克隆抗体。他们还有两个临床前抗体项目，FL-302和FL-501。
董事
名称
职位
Douglas E. Onsi
Director,Chief Executive Officer and President
Khing Oei
Director and Non-Executive Chairman
Thomas Dietz
Lead Independent Director
William McEvoy
Director and Chief Investment Officer
Christian Richard
Director
Christopher K. Mirabelli
Director
James Cavanaugh
Director
Joseph Loscalzo
Director
Nissim Mashiach
Director
Patricia Martin
Director
Richard Schilsky
Director
William Li
Director
股东
名称
职位
Douglas E. Onsi
Director,Chief Executive Officer and President
Christine Granfield
Vice President, Head of Regulatory Affairs and Quality
Jason Baum
Chief Scientific Officer
Mark O'Mahony
Chief Manufacturing Officer
William McEvoy
Director and Chief Investment Officer
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CYPH/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYPH\",,,,,undefined,":{"symbol":"CYPH","market":"US","secType":"STK","nameCN":"Cypherpunk Technologies Inc.","latestPrice":2.75,"timestamp":1763154000000,"preClose":1.76,"halted":0,"volume":263218687,"hourTrading":{"tag":"盘后","latestPrice":2.6997,"preClose":2.75,"latestTime":"19:59 EST","volume":3543392,"amount":9502570.0282,"timestamp":1763168399545},"delay":0,"floatShares":49877123,"shares":56651840,"eps":-1.600252,"marketStatus":"休市中","change":0.99,"latestTime":"11-14 16:00:00 EST","open":2.06,"high":3.55,"low":1.8901,"amount":766250655.3519601,"amplitude":0.943125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.600252,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1763370000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":2.0698,"preClose":1.76,"latestTime":"09:29 EST","volume":6354910,"amount":13097256.620515,"timestamp":1763130594895},"postHourTrading":{"tag":"盘后","latestPrice":2.6997,"preClose":2.75,"latestTime":"19:59 EST","volume":3543392,"amount":9502570.0282,"timestamp":1763168399545},"volumeRatio":1.5885906267835666,"impliedVol":2.985,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYPH\",,,,,undefined,":{"symbol":"CYPH","floatShares":49877123,"roa":"--","roe":"--","lyrEps":-1.811498,"volumeRatio":1.5885906267835666,"shares":56651840,"dividePrice":0,"high":3.55,"amplitude":0.943125,"preClose":1.76,"low":1.8901,"week52Low":0.2223,"pbRate":"--","week52High":3.58,"institutionHeld":0,"latestPrice":2.75,"eps":-1.600252,"divideRate":0,"volume":263218687,"delay":0,"ttmEps":-1.600252,"open":2.06,"prevYearClose":2.875,"prevWeekClose":0.4583,"prevMonthClose":0.4472,"prevQuarterClose":0.454,"fiveDayClose":0.4583,"twentyDayClose":0.5515,"sixtyDayClose":0.275},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"CYPH","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2025-08-14","symbol":"CYPH","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-05-13","symbol":"CYPH","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-03-26","symbol":"CYPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-11-13","symbol":"CYPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1738386000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":118044172,"yearFounded":2011,"employeeNum":52,"address":"47 Thorndike Street,Suite B1-1,Cambridge,Massachusetts,United States","zipCode":"02141","officePhone":"617 714 0360"},"stockCompanyDetail":{"websiteUrl":"http://www.leaptx.com","stockEarnings":[{"period":"1week","weight":5.0004},{"period":"1month","weight":3.4071},{"period":"3month","weight":9.2574},{"period":"6month","weight":5.8579},{"period":"1year","weight":-0.0484},{"period":"ytd","weight":-0.0435}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1308},{"period":"1year","weight":0.1324},{"period":"ytd","weight":0.1465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cypherpunk Technologies Inc.最初作为Dekkun Corporation成立于2011年1月3日，是一家特拉华州公司。2025年11月13日，公司更名为Cypherpunk Technologies Inc.。该公司是一家开发新型生物标志物靶向抗体疗法的生物制药公司，旨在通过抑制基本的肿瘤促进途径、靶向癌症特异性细胞表面分子和利用免疫系统攻击癌细胞来治疗癌症患者。他们的策略是识别、获取和开发分子，这些分子将迅速转化为高影响的治疗方法，产生持久的临床效益并提高患者的预后。他们的主要临床阶段项目是DKN-01，一种抑制dickkopf相关蛋白1(“DKK1”)的单克隆抗体。他们目前正在多个正在进行的临床试验中研究DKN-01在食管胃癌、妇科癌症或结直肠癌患者中的应用。他们的第二个临床阶段项目是FL-301，这是一种针对细胞表面表达Claudin18.2的细胞的单克隆抗体。他们还有两个临床前抗体项目，FL-302和FL-501。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.027306},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.021879},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.077902},{"month":4,"riseRate":0.444444,"avgChangeRate":0.024066},{"month":5,"riseRate":0.333333,"avgChangeRate":0.10817},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.10012},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017339},{"month":8,"riseRate":0.333333,"avgChangeRate":0.008005},{"month":9,"riseRate":0.444444,"avgChangeRate":0.109211},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.026459},{"month":11,"riseRate":0.333333,"avgChangeRate":0.497517},{"month":12,"riseRate":0.5,"avgChangeRate":0.157619}],"exchange":"NASDAQ","name":"Cypherpunk Technologies Inc.","nameEN":"Cypherpunk Technologies Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CYPH\",market:\"US\",,,undefined,":{"directors":[{"name":"Douglas E. Onsi","position":"Director,Chief Executive Officer and President"},{"name":"Khing Oei","position":"Director and Non-Executive Chairman"},{"name":"Thomas Dietz","position":"Lead Independent Director"},{"name":"William McEvoy","position":"Director and Chief Investment Officer"},{"name":"Christian Richard","position":"Director"},{"name":"Christopher K. Mirabelli","position":"Director"},{"name":"James Cavanaugh","position":"Director"},{"name":"Joseph Loscalzo","position":"Director"},{"name":"Nissim Mashiach","position":"Director"},{"name":"Patricia Martin","position":"Director"},{"name":"Richard Schilsky","position":"Director"},{"name":"William Li","position":"Director"}],"executives":[{"name":"Douglas E. Onsi","position":"Director,Chief Executive Officer and President"},{"name":"Christine Granfield","position":"Vice President, Head of Regulatory Affairs and Quality"},{"name":"Jason Baum","position":"Chief Scientific Officer"},{"name":"Mark O'Mahony","position":"Chief Manufacturing Officer"},{"name":"William McEvoy","position":"Director and Chief Investment Officer"}]}}}